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We investigated the antimicrobial susceptibility of 50 environmental isolates of Vibrio
cholerae non-O1/non-O139 collected in surface waters in Haiti in July 2012, during
an active cholera outbreak. A panel of 16 antibiotics was tested on the isolates using
the disk diffusion method and PCR detection of seven resistance-associated genes
(strA/B, sul1/2, ermA/B, andmefA). All isolates were susceptible to amoxicillin-clavulanic
acid, cefotaxime, imipenem, ciprofloxacin, norfloxacin, amikacin, and gentamicin. Nearly
a quarter (22.0%) of the isolates were susceptible to all 16 antimicrobials tested and
only 8.0% of the isolates (n = 4) were multidrug-resistant. The highest proportions
of resistant isolates were observed for sulfonamide (70.0%), amoxicillin (12.0%), and
trimethoprim-sulfamethoxazole (10.0%). One strain was resistant to erythromycin and
one to doxycycline, two antibiotics used to treat cholera in Haiti. Among the 50 isolates,
78% possessed at least two resistance-associated genes, and the genes sul1, ermA,
and strB were detected in all four multidrug-resistant isolates. Our results clearly indicate
that the autochthonous population of V. cholerae non-O1/non-O139 found in surface
waters in Haiti shows antimicrobial patterns different from that of the outbreak strain.
The presence in the Haitian aquatic environment of V. cholerae non-O1/non-O139 with
reduced susceptibility or resistance to antibiotics used in humanmedicine may constitute
a mild public health threat.
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INTRODUCTION
Reports on clinical strains of Vibrio cholerae O1 resistant to commonly used antibiotics are on
the rise (Garg et al., 2000, 2001; Ghosh and Ramamurthy, 2011; Harris et al., 2012). Antibiotic
resistance is a global health concern because resulting infections can be more difficult to treat.
The increase in resistance to antimicrobial drugs can result either from the accumulation of
genetic mutations, following exposure of the circulating bacteria to antibiotics during the medical
treatment of epidemics, or from the acquisition of resistance genes, through the mobilization and
exchange of a variety of genetic elements. In the case of V. cholerae, self-transmissible mobile
genetic elements may harbor an SXT constin (a large conjugative element), which may confer
resistance to sulfamethoxazole, trimethoprim, chloramphenicol, and streptomycin (Hochhut et al.,
2001).
Baron et al. Antimicrobial Susceptibility of Vibrio cholerae, Haiti
Surprisingly, data on the susceptibility of environmental
isolates of V. cholerae non-O1/non-O139 are still scarce (Kumar
et al., 2009; Bier et al., 2015; Bhuyan et al., 2016). However,
knowledge on the prevalence of antimicrobial resistance in these
serogroups is of global health interest for two reasons.
First, contrary to O1/O139, non-O1/non-O139 serogroups are
detected worldwide in all types of waters: freshwater, estuarine,
saline water, and wastewater. Aquatic environments may
provide an ideal setting for the acquisition and dissemination
of antibiotic resistance: (i) they are frequently affected by
anthropogenic activities (Marti et al., 2014); (ii) they contain
autochthonous bacterial flora that may harbor resistance-
associated genes; (iii) they bring bacteria from different origins
(human, livestock, etc.) into contact with each other; (iv) they can
contain antimicrobials or biocides which may select for resistant
bacteria. Wastewater constitutes a hot spot for the emergence
of antimicrobial resistance (Rizzo et al., 2013), particularly for
V. cholerae, which has a dual life cycle (intestinal and aquatic);
(Schoolnik and Yildiz, 2000). Therefore, due to its specific
genetic abilities, and its ecological characteristics, V. cholerae
may be an important vehicle of transmission of resistance genes
in all aquatic environments either within bacterial species or
between bacterial genera. In countries with endemic cholera,
these autochthonous aquatic serogroups of V. cholerae can
also co-infect cholera cases, providing an opportunity for the
exchange of antimicrobial resistance genes with clinical strains
of serogroup O1 in the human intestinal lumen. Furthermore,
the intestinal epidemic clones circulating in the environment can
theoretically exchange resistance genes with the autochthonous
populations of V. cholerae.
Second, some clones of V. cholerae non-O1/non-O139 from
aquatic environments may be opportunist pathogens, which can
cause gastro-intestinal or extra-intestinal infections (bacteremia,
septicemic, otitis, etc.) (Lukinmaa et al., 2006; Deshayes et al.,
2015). Throughout the world, the number of cases of V. cholerae
non-O1/non-O139 infections are rising (Baker-Austin et al.,
2013); moreover, reports of very severe infections are becoming
more frequent, with even one death recently reported in Austria
(Hirk et al., 2016). In Haiti, V. cholerae non-O1/non-O139 has
been shown to be a local intestinal infectious pathogen. Very early
in the on-going Haitian cholera outbreak (November 2010), a
microbiological investigation of 81 clinical cases of acute diarrhea
with varying severity from 18 towns showed that V. cholerae
non-O1/non-O139 was isolated from 28% of the stool specimens,
either alone (n = 17) or in co-culture with toxigenic V. cholerae
O1 (n = 5). The latter cases were confirmed cholera cases, as
were 39 other cases with the presence of toxigenic V. cholerae
O1 alone (Hasan et al., 2012). However two years later (from
April 2012 to March 2013), systematic testing of profuse watery
diarrhea cases was carried out in four hospitals that had cholera
treatment facilities. Among the 1616 specimens of stools tested
in culture, 60% were positive for toxigenic V. cholerae O1, one
gave a non-toxigenic isolate of V. cholerae O1, but none were
positive for V. cholerae non-O1/non-O139 (Steenland et al.,
2013). Other studies on stools collected from patients during
the Haiti outbreak found only serogroup O1 isolates (Talkington
et al., 2011; Katz et al., 2013). These results are not contradictory:
non-O1/non-O139 serogroups can cause a diarrheal disease that
is generally less severe than cholera and do not particularly
have epidemic potential (Menon et al., 2009). Nevertheless,
the pathogenic clones of V. cholerae, whether they are agents
of cholera or of milder infections, can circulate via aquatic
environments and some authors even speculate that toxigenic
clones of V. cholerae are autochthonous to estuaries and rivers
systems worldwide as are other clones (Colwell, 1996).
We therefore investigated the antimicrobial susceptibility of
50 environmental isolates of non-toxigenic V. cholerae collected
in various surface waters in Haiti in July 2012, during the active
cholera epidemic (Baron et al., 2013). The aim of this study
was to document, in this context, the susceptibility of strains
belonging to non-O1/non-O139 serogroups to 16 antibiotics
used and compare it to those of the Haitian epidemic strain.
MATERIALS AND METHODS
Collection of Strains
In a previous study, water samples, including wastewater,
were collected from 35 stations described in Baron et al.
(2013). V. cholerae was detected by culturing samples on TCBS
(thiosulfate citrate bile sucrose) agar (Difco, BD Biosciences,
Le pont de Claix, France) after enrichment in peptone alkaline
saline water (41◦C ± 1 for 16–24 h; Muic, 1990). Presumptive
identification of V. cholerae was given to all sucrose-fermenting
isolates that were able to grow on nutrient agar without added
NaCl, and that tested positive for oxidase (Baron et al., 2007).
Presumptive V. cholerae were isolated from 27 of the 35 stations
sampled, but isolates from six stations could not be regrown
(Table 1).
Fecal contamination (FC) was determined using PetrifilmTM
Select Escherichia coli (Département Microbiologie Laboratoires
3M Santé, Cergy, France). Based on the FC level (Table 1), the
21 sampled stations were divided into two groups. The high
FC (HFC) group for which the density of E. coli was at least
104 CFU/100mL included five stations that were all wastewaters.
The low FC (LFC) group, for which the E. coli density level was
<104 CFU/100mL, included Trou Caïman Lake (Station 3) and
Etang Saumâtre Lake (Stations 4 and 5; Table 1). Conductivity
was assessed at the laboratory with a field conductometer (Hanna
HI-99301, Grosseron, Nantes, France).
Confirmation and Characterization of
V. cholerae
Agglutination using a polyclonal antibody specific to the O1
surface antigen (Bio-Rad, Marnes-la-Coquette, France) was
performed on presumptive V. cholerae isolates at the Haiti
National Public Health Laboratory. A saline solution was used
as a control to identify self-agglutinating isolates. One isolate
per enrichment and per station was conserved and sent to the
ANSES-Laboratory of Ploufragan-Plouzané for further analysis.
The identification of presumptive V. cholerae was confirmed by
PCR (Nandi et al., 2000). The genes coding for the O1 and
O139 surface antigens (rfb) were assessed with PCR using O1-
and O139-specific primers (Hoshino et al., 1998; Table 2). The
cholera toxin gene ctxA was screened using PCR (Hoshino et al.,
1998; Nandi et al., 2000).
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TABLE 1 | Distribution of the 50 isolates of confirmed V. cholerae non-O1/non-O139 and characteristics of the 27 stations (see Baron et al., 2013 for
correspondence).
Sampling stations Water characteristics Number of isolates
Department Town Location IDa Salinity (‰)b Fecal contamination:
E. coli /100mL Groupd
West (Metropolitan area) Port-au-Prince Martissant (street wastewater) 2 NDc ND HFC 2
West (Metropolitan area) Carrefour Mariani (wastewater in the river) 32 0.21 106,000 HFC NGe
West (Metropolitan area) Carrefour Mariani (river shore) 33 0.20 35,000 HFC 2
West (Metropolitan area) Carrefour Mariani (river shore) 34 0.21 46,000 HFC 3
West (Metropolitan area) Carrefour Mariani (macrophyte lagoon) 35 25.02 12,400 HFC NG
West (Metropolitan area) Carrefour Mariani (macrophyte lagoon) 36 10.72 50,000 HFC NG
Artibonite Gonaives Small canal of wastewater 19 2.09 91,000 HFC 4
Artibonite Gonaives Large canal of wastewater 24 1.40 36,000 HFC 3
West Thomazeau Trou Caïman Lake 3 1.27 ND LFC 3
West Thomazeau Etang Saumâtre Lake (shore) 4 4.90 ND LFC 3
West Thomazeau Etang Saumâtre Lake (far from the shore) 5 5.62 ND LFC 2
Artibonite Saint Marc Etang Bois-Neuf 18 12.41 2000 LFC 5
Artibonite Saint Marc Pont-Sondé (Artibonite River) 6 0.14 4800 LFC 4
Artibonite Grande Saline Main canal 1 17 0.15 2800 LFC 2
Artibonite Grande Saline Main canal 2 16 0.15 3600 LFC 2
Artibonite Grande Saline Drouin—main canal 3 (point-of-use) 7 0.15 2100 LFC 2
Artibonite Grande Saline Artibonite River estuary 1 9 0.14 2100 LFC 1
Artibonite Grande Saline Artibonite River estuary 2 10 0.15 3100 LFC 1
Artibonite Grande Saline Basin 1 14 0.75 1000 LFC 1
Artibonite Grande Saline Basin 2 15 0.27 <100 LFC 4
Artibonite L’Estère L’Estère (river) 25 0.15 300 LFC 1
Artibonite L’Estère L’Estère (small canal) 26 0.15 400 LFC 1
Artibonite L’Estère L’Estère (large canal) 27 0.14 300 LFC 1
Artibonite L’Estère L’Estère (roadside) 28 0.37 4700 LFC NG
Artibonite Desdunes Route de Desdunes (small canal) 29 0.26 200 LFC NG
Artibonite Desdunes Route de Desdunes (large canal) 30 0.52 300 LFC 3
Artibonite Desdunes Route de Desdunes (rice field) 31 0.30 <100 LFC NG
a ID, identification number of the station;
bsalinity: fresh water <0.5‰; brackish water 0.5–16‰;
cND, no data;
dHFC, high fecal contamination: E. coli >104 CFU/100mL; LFC, low fecal contamination: E. coli ≤104 CFU/100mL;
eNG, isolate from the National Health of Public Health in Haiti did not grow in the ANSES laboratory.
Antibiotic Resistance Profiles
The susceptibility of V. cholerae isolates was tested using the
disk diffusion method according to Clinical and Laboratory
Standards Institute (CLSI) guidelines (CLSI, 2010a) for the 16
following antimicrobial agents: ampicillin, amoxicillin-clavulanic
acid, cefotaxime, imipenem, chloramphenicol, nalidixic acid,
ciprofloxacin, norfloxacin, amikacin, gentamicin, streptomycin,
tetracycline, doxycycline, sulfonamide, trimethoprim-
sulfamethoxazole, and erythromycin (Table 3). E. coli ATCC
25922 served as a positive control. The CLSI interpretative
criteria for disk diffusion susceptibility testing of Vibrio spp.
(CLSI, 2010a) were used when available. For nalidixic acid,
norfloxacin, amikacin, and streptomycin, the interpretative
criteria for Enterobacteriaceae were used (CLSI, 2016; Table 3).
No criteria were available for erythromycin or doxycycline;
therefore, the distribution of the inhibition diameters was
recorded and interpretation was based on obtained distribution
plots. The separation between wild-type (microorganisms
without acquired resistance mechanisms) and non-wild-
type populations (microorganisms with acquired resistance
mechanisms) was determined by visual inspection of the
diameter distribution (Hombach et al., 2014). Wild-type
populations were considered as susceptible populations and
non-wild-type as resistant populations. The few intermediate
results were categorized as resistant for this study.
Genes associated with resistance to streptomycin (strA and
strB) and to sulfonamide (sul1 and sul2)-which may be associated
with the presence of V. cholerae SXT-as well as genes associated
with erythromycin resistance (ermA, ermB, and mefA)-an
antimicrobial agent used in Haiti for cholera treatment-were
detected using PCR (Pei et al., 2006; Popowska et al., 2012; Di
Cesare et al., 2013). Class 1, 2, and 3 integrons were screened
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TABLE 2 | List of primers used in this study.
Targeted gene Primer name Primer sequence (5′–3′) T◦Ca Amplicon size (bp) References
ermA ermA1 TAACATCAGTACGGATATTG 54 139 Di Cesare et al., 2013
ermA2 AGTCTACACTTGGCTTAGG
ermB ermB1 CCGAACACTAGGGTTGCTC 54 200 Di Cesare et al., 2013
ermB2 ATCTGGAACATCTGTGGTATG
mef mef1 AGTATCATTAATCACTAGTGC 54 348 Di Cesare et al., 2013
mef2 TTCTTCTGGTACTAAAAGTGG
sul1 Sul1-1 CGCACCGGAAACATCGCTGCAC 65 162 Pei et al., 2006
Sul1-2 TGAAGTTCCGCCGCAAGGCTCG
sul2 Sul2-1 TCCGGTGGAGGCCGGTATCTGG 57.5 190 Pei et al., 2006
Sul2-2 CGGGAATGCCATCTGCCTTGAG
O139 rfb O139-1 AGCCTCTTTATTACGGGTGG 55 449 Hoshino et al., 1998
O139-2 GTCAAACCCGATCGTAAAGG
O1 rfb O1-1 GTTTCACTGAACAGATGGG 55 192 Hoshino et al., 1998
O1-2 GGTCATCTGTAAGTACAAC
ctxA ctx Ats CTCAGACGGGATTTGTTAGGCACG 64 301 Nandi et al., 2000
ctx A TCTATCTCTGTAGCCCCTATTACG
ompW ompW ts CACCAAGAAGGTGACTTTATTGTG 64 588 Nandi et al., 2000
ompW ta GAACTTATAACCACCCGCG
strA strA-F GAGAGCGTGACCGCCTCATT 57 862 Popowska et al., 2012
strA-R TCTGCTTCATCTGGCGCTGC
strB strB-F GCTCGGTCGTGAGAACAATC 54 859 Popowska et al., 2012
strB-R AGAATGCGTCCGCCATCTGT
aAnnealing temperature.
using PCR (Barraud et al., 2010). All primer pairs, target genes,
corresponding annealing temperatures, and amplicon sizes are
listed in Table 2.
RESULTS
Collection of Isolates
The collection was composed of 50 isolates of V. cholerae from
21 stations (Table 1): 36 (72.0%) were isolated from the 16 LFC
stations and 14 from the 5 HFC stations (for description of
stations see Baron et al., 2013). None of the 50V. cholerae isolates
belonged to O1 or O139 serogroups nor produced the cholera
toxin (i.e., the ctxA gene was not detected).
Antibiotic Resistance Phenotypes
All tested isolates were susceptible to seven antibiotics of the
tested panel: amoxicillin/clavulanic acid, cefotaxime, imipenem,
ciprofloxacin, norfloxacin, amikacin, and gentamicin. Eleven
isolates (22.0%) were susceptible to all 16 tested antibiotics (three
isolates out of 14 from the HFC group and eight out of 36 from
the LFC group). The highest proportions of resistant isolates
were observed for sulfonamide (70.0%), ampicillin (12.0%), and
trimethoprim-sulfamethoxazole (10.0%; Table 4).
One isolate, VCH126 from HFC station 19, showed a smaller
inhibition zone (15mm) for doxycycline than the 49 other
isolates (Figure 1B) and was resistant to tetracycline. Given
that the results from the tetracycline disk are typically used to
predict susceptibility to doxycycline (Centers for Disease Control
Prevention, 1999), we concluded that VCH126 was resistant
to doxycycline. VCH3, isolated from LFC station 2, showed
an inhibition zone of 7mm for erythromycin (Figure 1A); this
isolate was declared resistant to erythromycin.
Among the 39 isolates that were resistant to at least one
antibiotic, 12 different profiles were observed. The dominant
profile was resistance to sulfonamide only (n = 26/39; 66.7%),
and the 11 other profiles were represented by only one or two
isolates (Figure 2). Antimicrobial resistance was not significantly
different between LFC and HFC stations (Fisher exact test; p =
0.91).
Multidrug resistant isolates are defined as isolates which
are resistant to at least three different antimicrobial classes
(Magiorakos et al., 2012). Four isolates (10.5%), VCH3, VCH126,
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TABLE 3 | Interpretative criteria used to determine antimicrobial susceptibility with the disk diffusion test in Vibrio cholerae isolates.
Antimicrobial class Antimicrobial agent Abbreviation Disk content (µg) Zone diameter interpretative criteria (mm) References
Susceptible Intermediate Resistant
ß-lactams Ampicillin AM 10 ≥17 14–16 ≤13 CLSI, 2010a
Amoxicillin-clavulanic
acid
AMC 20/10 ≥18 14–17 ≤13 CLSI, 2010a
Cefotaxime CTX 30 ≥26 23–25 ≤22 CLSI, 2010a
Imipenem IPM 10 ≥23 20–22 ≤19 CLSI, 2010a
Phenicols Chloramphenicol C 30 ≥18 13–17 ≤12 CLSI, 2010a
Aminoglycosides Amikacin AMK 30 ≥17 15–16 ≤14 CLSI, 2010a
Gentamicin GEN 10 ≥15 13–14 ≤12 CLSI, 2010a
Streptomycin STR 10 ≥17 13–16 ≤12 CLSI, 2016
Quinolones Ciprofloxacin CIP 5 ≥21 16–20 ≤15 CLSI, 2010a
Nalidixic acid NA 30 ≥19 14–18 ≤13 CLSI, 2016
Norfloxacin NOR 10 ≥17 13–16 ≤12 CLSI, 2016
Folate pathway inhibitors Sulfonamide SSS 300 ≥17 13–16 ≤12 CLSI, 2010a
Trimethoprim-
sulfamethoxazole
SXT 1.25/23.75 ≥16 11–15 ≤10 CLSI, 2010a
Tetracyclines Tetracycline TET 30 ≥15 12–14 ≤11 CLSI, 2010a
Doxycycline DO 30 – – –
Macrolides Erythromycin ERY 15 ≥17 13–16 ≤12 CLSI, 2016
Interpretative criteria specific for Vibrio spp., including V. cholerae described in CLSI document M45 3rd edition (CLSI, 2010a) are adapted from those for Enterobacteriaceae M100
25S (CLSI, 2010b). For streptomycin, norfloxacin and nalidixic acid breakpoints described for Enterobacteriaceae in M100 26S (CLSI, 2016) were used. No breakpoints were available
for doxycycline or for erythromycin.
VCH85, and VCH55, were multidrug-resistant (Table 4). They
displayed four different profiles (Figure 2). The four isolates were
all resistant to streptomycin and sulfonamide, but none were
resistant to nalidixic acid. Two isolates (VCH3 and VCH126),
from stations 2 and 19, were resistant respectively to six and
four classes of antimicrobials. They were both resistant to
the antimicrobials belonging to the classes of folate pathway
inhibitors (trimethoprim-sulfamethoxazole, sulfonamide),
phenicols, tetracycline, and aminoglycosides. These phenotypic
resistances may be conferred by genes that are frequently
associated with the presence of an SXT element. Nevertheless,
the class 1 integron integrase gene was detected in one isolate
(VCH3) only. VCH3 was also resistant to erythromycin and
ampicillin, but susceptible to doxycycline. VCH126 was also
resistant to doxycycline.
Antibiotic Resistance Genotypes
Seven resistance-associated genes were screened on the 50
isolates, regardless of the resistance profile. We chose to
screen for resistance associated with streptomycin (strA/B) and
sulfonamide (sul1/2), because these genes can be present in the
SXT constin, and with erythromycin (ermA/B, mefA) which is
used in Haiti for cholera treatment.
Among the 50 isolates, 78% possessed at least two resistance-
associated genes (Figure 3). The genes sul1, ermA, and strB
were detected in the four multidrug-resistant isolates. Three of
these isolates harbored five resistance-associated genes and one
harbored four genes (Figure 3). The sul1 gene was detected in 41
(82%) isolates. The sul2 gene was detected only in three isolates
(6.0%) and always in association with sul1; these isolates were
resistant to sulfonamide. The strA gene was detected only in
three isolates (6.0%) and always in association with strB; these
three isolates were resistant to streptomycin. In contrast, the two
other isolates that were resistant to streptomycin did not harbor
either strA or strB. StrB gene was detected in 11 other isolates
that were susceptible to streptomycin. ErmA gene was detected in
90.0% of the isolates, while only one strain (VCH3) was resistant
to erythromycin; this strain harbored only ermA. MefA was
detected in only one strain (VCH90) which also carried the ermA
gene, but was susceptible to erythromycin (Table 4).
DISCUSSION
Only few studies have investigated the presence of resistance-
associated genes in V. cholerae non-O1/non-O139 strains in
association with phenotypic susceptibility (Raissy et al., 2012;
Bier et al., 2015; Bhuyan et al., 2016). One study was carried
out on 184 V. cholerae non-O1/non-O139 strains of clinical
and environmental origin (water and fish), and showed that 11
were resistant to ampicillin, but all were sensitive to the other
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FIGURE 1 | Distribution of diffusion zone diameters: (A) erythromycin (15µg); (B) doxycycline (30µg).
beta-lactam antibiotics tested, with the exception of four strains
resistant to carbapenems (Bier et al., 2015). However, no beta-
lactamase-coding genes were found. The other study screened
for three resistance-associated genes (ermB, strA, and sul2) on
three strains of V. cholerae isolated from seafood in Iran. Only
the strA gene was detected in one isolate which was resistant to
streptomycin, amikacin, and gentamicin (Raissy et al., 2012).
In this study, we detected strA in three isolates which
were resistant to streptomycin but susceptible to the other
aminoglycosides tested. The ermA gene was not detected, but the
ermB gene was detected in 90% of V. cholerae isolates, although
only one isolate showed a resistance phenotype. This gene, which
codes for the methylation of the target, is frequently detected in
Staphylococcus spp. On the contrary, one strain possessed both
the ermA gene and the mefA gene, which codes for an eﬄux
pump, another mechanism of resistance. Nonetheless, this isolate
presented a susceptible phenotype (zone of inhibition= 17mm).
Our study indicates that the PCR and susceptibility testing
approaches are complementary, because they show the presence
of genes associated with resistance in susceptible strains and
also their absence in resistant strains. This indicates that
the link between genes and phenotypes is probably complex.
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FIGURE 2 | Distribution of resistance profiles in V. cholerae non-O1/non-O139 isolates. The number of isolates for each resistance profile is indicated in
brackets, and isolate identity is indicated only for the four multidrug-resistant strains. AM, Ampicillin; C, chloramphenicol; NA, nalidixic acid; STR, streptomycin; TET,
tetracycline; DO, doxycycline; SSS, sulfonamide; SXT, trimethoprim-sulfamethoxazole; ERY, erythromycin. SXT and SSS belong to the class of folate inhibitor pathway
and DO and TET to the tetracycline class.
FIGURE 3 | Distribution of the profiles of resistance-associated genes
in the 50 V. cholerae non-O1/non-O139 isolates.
Interestingly, the multidrug-resistant isolates were those that
harbored the highest number of resistance-associated genes.
Even if a larger panel of associated resistance genes could be
investigated, it would not be exhaustive.
Screening for resistance genes is just a first step: it
provides information on the reservoir of resistance genes
in the autochthonous aquatic V. cholerae non-O1/non-O139
population in our collection of isolates. The next step requires
the localization of these genes (chromosome, plasmid, ICE) to
estimate their potential for dissemination more precisely. Some
of these resistance-associated genes are associated with mobile
genetic elements. The sul1/2 genes have been detected in class
1 integrons or/and in plasmids in V. cholerae O1 (Dalsgaard
et al., 2001; Iwanaga et al., 2004; Ceccarelli et al., 2006) and
in non-O1/non-O139 serogroups (Dalsgaard et al., 2000). The
strA/B genes are associated with the class 1 integron as well
as the SXT element (Hochhut et al., 2001; Iwanaga et al.,
2004) in V. cholerae O1. In this study, a class 1 integron
was detected in only one strain (VCH3), which showed the
expected multidrug resistance (chloramphenicol, trimethoprim-
sulfamethoxazole, ampicillin, tetracycline, and sulfonamide) that
can be harbored by the SXT/R391 integrative and conjugative
element (ICE). In Haiti, Ceccarelli et al. (2013) described the
presence of two types of SXT/R391 ICEs displaying different
genetic organizations, one in O1 serogroup strains (ICEVchHai1)
and another (ICEVchHai2) in some clinical isolates of non-
O1/non-O139 serogroups (Ceccarelli et al., 2013). ICEVchHai2
lacks the antibiotic resistance cluster typically inserted in
variable region 3. It remains to be seen whether VCH3
harbors an ICE and, if so, which genetic organization it
possesses.
Considering the Haitian situation, we compared the
susceptibility profiles of the non-O1/non-O139 isolates with
those of V. cholerae O1 of either clinical or environmental
origin, which have been published since the beginning of the
cholera outbreak in October 2010 (Sjölund-Karlsson et al., 2011;
Talkington et al., 2011; Alam et al., 2014, 2015; Folster et al.,
2014). Our results clearly indicate that the non-O1/non-O139
V. cholerae isolated from surface waters showed phenotypical
antimicrobial patterns different from those of the epidemic
strain.
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Two collections of toxigenic V. cholerae O1 strains have been
tested for antimicrobial susceptibility: 122 laboratory-confirmed
V. cholerae O1 clinical isolates, recovered by the National
Public Health Laboratory in Haiti from October 2010 to
January 2011 (Sjölund-Karlsson et al., 2011) and 17 toxigenic
V. cholerae O1 isolates collected from surface waters in the
West Department from April 2013 to March 2014 (Alam et al.,
2015). These V. cholerae O1 strains, regardless of their origin
(clinical or environmental) all displayed the same multidrug
resistance profile: resistance to streptomycin, sulfamethoxazole,
trimethoprim-sulfamethoxazole, and nalidixic acid. The 50
V. cholerae non-O1/non-O139 strains collected in our study
displayed 12 different profiles of resistance but only 8.0% of
them were multidrug resistant. Two multidrug-resistant strains
isolated from wastewater were resistant to four and six families
of antibiotics. None of the four multidrug-resistant non-O1/non-
O139 isolates studied displayed the phenotypical profile of the
O1 serogroup. In the Alam et al. (2015) study, all 17 isolates
of V. cholerae O1 from aquatic environments were susceptible
to doxycycline, tetracycline, chloramphenicol, and ampicillin. In
contrast, among the non-O1/non-O139 isolates in this study,
some were resistant to doxycycline (1 strain), tetracycline (2
strains), chloramphenicol (3 strains), and ampicillin (6 strains),
and one was resistant to erythromycin.
In another collection of 1029 V. cholerae O1 strains collected
from 18 towns in Haiti from April 2012 to March 2013, the 115
V. cholerae tested by CDCAtlanta (Steenland et al., 2013) showed
100% susceptibility to ampicillin and to tetracycline, whereas a
fraction of our V. cholerae non-O1/non-O139 were resistant to
ampicillin and tetracycline (respectively 12.0 and 4.0%).
These differences of susceptibility profile between the strains
of V. cholerae non-O1/non-O139 studied and the profile of
O1 epidemic strains of Haiti could be partly linked to a
difference in the history of exposure to antibiotics. Given that
V. cholerae non-O1/non-O139 serogroups isolates studied were
collected in aquatic environment, we could rise the hypothesis
that they have not experienced the same selection pressure
as the toxigenic V. cholerae. Therefore, because doxycycline,
tetracycline, and erythromycin are currently used in the
treatment of diarrheal diseases in Haiti, the resistance acquired
here by aquaticV. cholerae non-O1/non-O139 to these antibiotics
may be due to selection pressure on local enteropathogenic
bacteria. Accordingly, among the four multidrug-resistant
isolates of V. cholerae non-O1/non-O139 detected in this study,
the two strains harboring resistance to the most antibiotics
(four and six different classes of antibiotics, respectively, for
VCH126 and VCH3) came from raw wastewater (VCH 126
in Gonaives and VCH3 in Martissant) and these two strains
were resistant to two of the three antibiotics used locally:
VCH126 was resistant to tetracycline and to doxycycline and
VCH3 was resistant to erythromycin and tetracycline but not to
doxycycline.
In a previous study, Katz et al. discovered that the epidemic
clone is poorly transformable by horizontal gene transfer, and
they found no evidence that environmental strains have played
any role in its evolution (Katz et al., 2013). This could explain that
the susceptibility profile of the epidemic strain has not changed
since the beginning of the outbreak, except the single observation
of the variant 2012EL-2176 isolated from a clinical case in 2012.
That single variant showed the typical resistance phenotype
of the outbreak strain, but additional resistance to ampicillin
had been acquired and the minimum inhibitory concentration
of tetracycline had become intermediate (Folster et al., 2014).
Resistance to ampicillin and tetracycline were both found in our
non-O1/non-O139 isolates.
Nevertheless, to have information about the possibility
of genetic exchanges between non-O1/non-O139 V. cholerae
isolates and the O1 epidemic clone, deeper genetic investigations
are necessary for example by whole genome sequencing,
determination of the MLST profile or comparison of mutations
on targeted genes (ctxB, QRDR, etc.).
The prevalence of antibiotic resistance in non-O1/non-O139
V. cholerae in an endemic zone of cholera has also been studied
in Sanitpur, Assam, North East India (Bhuyan et al., 2016). A
collection of 107 strains of V. cholerae (among which a single
strain of O1 Ogawa) was isolated from 38 water samples (river
Brahmapoutra and its tributaries, canal, tea garden) before the
rainy season and during monsoon (flooding) in 2012 and 2014.
Antibiotic susceptibility was tested by the same disk diffusion
method, allowing comparisons with our results. The dominant
resistance to sulfonamide in Haïti (70%) was consistent with
the dominant resistance to sulfamethoxazole (around 60%).
Resistance to two antibiotics was much more frequent in Assam
than in Haïti: streptomycin (respectively around 50 vs. 10%), and
nalidixic acid (around 50 vs. 4%). Resistance to three antibiotics
was slightly more frequent in Assam than in Haïti: Ampicillin
(around 35 vs. 12%), Erythromycin (around 15 vs. 2%), and
tetracycline (around 10 vs. 4%). Two antibiotics gave opposite
results: resistance to chloramphenicol was present in Haiti (6%)
and absent in Assam; on the contrary, resistance to ciprofloxacin
was present in Assam (5%) and absent in Haïti. These differences
may be linked to sampling fluctuations but could also be linked
to different choices in the two countries for diarrheal diseases and
severe cholera treatment.
Thus, in cholera endemic context, the presence of V. cholerae
non-O1/non-O139 with reduced susceptibility or resistance to
antibiotics used for human medicine in the aquatic environment
may constitute a mild public health threat. Although the risk
of therapeutic failure for infections by a few multidrug-resistant
strains seems limited (and the incidence of such infections is
still unknown in Haiti), the screening for non-O1/non-O139
serogroups should be included in surveillance programs on
diarrhea outbreaks. Moreover, the hypothesis that the aquatic
population of V. choleraemay constitute a reservoir of resistance
genes, supplied by genetic exchanges in situ with enteric bacteria
such as E. coli, which do not survive in aquatic environments, still
needs to be investigated.
CONCLUSION
In the context of a cholera outbreak in Haiti, non-O1/non-
O139 V. cholerae in surface waters showed antimicrobial
patterns different from the epidemic strain: there were few
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multidrug-resistant strains and a high diversity of resistance
profiles, including resistance to doxycycline, tetracycline and
erythromycin. In contrast, according to the literature, all the
clinical and environmental isolates of toxigenic serogroup O1 in
Haiti were susceptible to these three antibiotics or had reduced
susceptibility (tetracycline) and all presented the same specific
multidrug-resistance profile.
However, the presence of acquired resistance to antibiotics
among the autochthonous V. cholerae non-O1/non-O139 in the
aquatic environment can be construed as the result of a local
selection pressure on enteric bacteria in Haiti, where the use of
antibiotics is not strictly regulated.
Further research is required to address this public health
issue. The ability of the autochthonous aquatic population of
V. cholerae non-O1/non-O139 to acquire and transfer resistance
genes, especially in wastewaters, needs to be investigated. In
addition, the contribution of the non-O1/non-O139 serogroups
to co-infections of cholera cases, or to diarrhea cases in Haiti,
should be documented as part of national surveillance programs
of gastro-intestinal infections.
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